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The clinicopathological differences between remnant gastric carcinoma (RGC) after
partial gastrectomy for benign disease (RGC-BD) and RGC after partial gastrectomy
for gastric carcinoma (RGC-GC) were evaluated.  The incidences of developing gastric
carcinomas in patients more than 10 years after partial gastrectomy for benign disease
or for gastric carcinoma were compared with those of developing gastric carcinomas in
patients with colorectal carcinoma who were determined to have no malignant disease
in the stomach preoperatively.  Next, we analyzed the clinicopathological differences
among RGC-BD, RGC-GC and primary gastric carcinoma (PGC) in the upper third of
the stomach.  RGC-BD was detected in 8 of 1,187 (0.7%) patients and RGC-GC was
detected in 19 of 764 (2.5%) patients.  Among the controls, 7 of 226 (3.1%) patients
developed gastric carcinoma.  The estimated risk of developing of RGC-BD and RGC-
GC were 0.12 and 0.798.  No difference was found among 18 patients with RGC-BD, 16
patients with RGC-GC and 229 patients with PGC in terms of patient age, histologic
type, tumor size and distribution of tumor stage.  The 5-year survival rate for patients
with PGC (55%) was not different from that for patients with RGC-BD (43%) or that
for patients with RGC-GC (65%).  However, the interval between initial operation and
detection of RGCs was longer in RGC-BD than in RGC-GC (P = 0.004), and RGCs
were more frequently detected at the site of anastomosis in patients with RGC-BD (50%)
than in patients with RGC-GC (19%, P = 0.057).  The incidence of developing RGCs
after partial gastrectomy for benign and malignant diseases was low.  The histologic
type of tumors and tumor stages of RGC-GC were not different from those of RGC-
BD; however, RGC-GC developed within a short time and most lesions were at sites
remote from the anastomosis.  These findings indicate that carcinogenesis of RGC-GC
appears to be different from that of RGC-BD.
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Carcinomas developing in the remnant stomach
after partial gastrectomy for benign gastroduo-
denal disease, such as gastric ulcer or duodenal
ulcer,  have been intensively investigated in
Western countries (Kivilaakso et al., 1977;
Northfield and Hall, 1990).  However, little data
exists on the group of patients who undergo a
partial gastric resection for gastric carcinoma,
later developing the second primary lesion in
the gastric remnant.  As a result of the increas-
ing number of patients who have undergone
gastrectomy for early gastric cancer in Japan,
the incidence of developing second primary
gastric cancer in the remnant stomach has
increased (Furukawa et al., 1993; Isozaki et al.,
1998).  However, the clinicopathological differ-
ence between the 2 types of gastric carcinomas
which developed in the remnant stomach (after
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partial gastrectomy for benign disease and after
partial gastrectomy for gastric carcinoma) has
not been well discussed.
In this study, we designed 2 studies to deter-
mine the difference between these 2 types of
gastric carcinomas in the remnant stomach
(remnant gastric carcinoma, RGC).  First, we
followed patients who had undergone distal
partial gastrectomy for benign disease or for
gastric carcinoma at our hospital, and compared
the incidences of developing gastric carcinomas
in the remnant stomachs.  Next, we analyzed the
clinicopathological differences between the 2
types of RGCs gastrectomized in our hospital.
Also, we compared the clinicopathological data
of patients with RGC with that of patients with
primary gastric carcinoma (PGC) which
developed in the upper third of the stomach.
Materials and Methods
Study design
In order to analyze the incidence of developing
gastric carcinoma in the remnant stomach, we
studied 2,880 patients (2,045 males, 835 fe-
males; mean age, 53.9 years; age ranges, 15–88
years) who underwent distal partial gastrec-
tomy between 1960 and 1985 in our hospital.
Billroth I (B-I) reconstruction was performed in
1,717 patients and Billroth II (B-II) reconstruc-
tion was performed in 1,163 patients.  Distal
partial gastrectomy was performed for benign
disease in 1,383 patients (1,072 males, 311 fe-
males; mean age, 49.6 years; age range, 15–86
years).  Benign gastroduodenal diseases in
1,383 patients included gastric ulcer (839), duo-
denal ulcer (273), polyp (150), gastritis (99) and
benign submucosal tumor (22).  Distal partial
gastrectomy was performed for gastric carcino-
ma in 1,497 patients (973 males, 524 females;
mean age, 58 years; age range, 21–88 years).
Tumor stages for these patients included Stages
IA (498), IB (222), II (249), IIIA (204), IIIB
(155) and IV (169).  These 2,880 patients were
followed till the end of 1999.  The mean follow-
up period was 210 months (range: 0–480 months).
The mean follow-up period of the 1,383 pa-
tients who underwent partial gastrectomy for
benign diseases was 282 months (range: 0–480
months) and that of the 1,497 patients who
underwent partial gastrectomy for gastric
carcinoma was 144 months (range: 0–469
months).  The follow-up records of patients
were obtained from our hospital and from affili-
ated hospitals.  For the controls, we investigated
the incidence of occurrence of gastric carcino-
ma in 516 patients (297 males, 219 females;
mean age, 60 years; age range, 22–91 years) with
colorectal carcinoma who underwent colorectal
resection between 1960 and 1985 in our
hospital.  These 516 patients were confirmed to
have no gastric carcinomas in the stomach prior
to colorectal operation by the upper barium gas-
trointestinal series or by the endoscopic studies.
They were followed up at our hospital till the
end of 1999.  The mean follow-up period of
these 516 patients was 121 months (range: 0–
473 months).
Between 1960 and 1993, 23 patients with
RGC after partial gastrectomy for benign dis-
ease (RGC-BD) and 37 patients with RGC after
partial gastrectomy for gastric carcinomas
(RGC-GC) were treated in our hospital.  In the
23 patients with RGC-BD, the first gastrecto-
mies for 6 patients were performed in our hospi-
tal and those for the remaining 17 patients were
done in other hospitals.  In the 37 patients with
RGC-GC, the first gastrectomies for 18 patients
were performed in our hospital and those for the
remaining 19 patients were done in other hospi-
tals.  In order to analyze the clinicopathological
differences between RGC-BD and RGC-GC,
we excluded 26 patients (RGC-BD: 5 patients
and RGC-GC: 21 patients) whose interval peri-
od between the initial gastrectomy and the de-
tection of carcinoma in the remnant stomach
was less than 10 years from our study; we could
not negate the possibility that some cancer
could have already developed in the upper third
of the stomach at the time of distal partial
gastrectomy for benign disease or for malignant
disease, and was  overlooked at the time of the
initial operation, nor could we negate the pos-
sibility of cancer recurrence in the remnant
stomach after distal partial gastrectomy for gas-
tric carcinoma.  Kidokoro et al. (1985) reported
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that the recurrence of gastric carcinoma usually
occurred within 10 years regardless of the initi-
al stage of disease.  To eliminate these possibi-
lities, an interval of more than 10 years is re-
quired between the initial partial gastrectomy
and the detection of carcinoma in the remnant
stomach (Takeda et al., 1992).  Thus, RGCs
(RGC-BD: 18 patients and RGC-GC: 16 pa-
tients) found after more than 10 years from ini-
tial gastrectomy are likely to represent true new
neoplasms.  As a control group for RGC, 299
patients with PGC located in the upper third of
the stomach who underwent gastrectomy
between 1960 and 1993 were investigated.
Clinicopathological and statistical anal-
ysis
Clinicopathological factors were determined in
accordance with criteria from the Japanese Re-
search Society for Gastric Cancer (1999).  His-
tological classifications of tumors followed the
criteria established by Laurén (1965).  The chi-
square test and Fisher’s exact probability test
were used to compare the distribution of indi-
vidual variables among the groups.  Differences
in the numerical data (patient age and tumor
size) among the groups were evaluated by the
Mann-Whitney U test or by the Kruskal-Wallis
test.  The survival distributions were estimated
using the method of Kaplan and Meier.  Cor-
rected survival rates were used; that is, only
deaths caused by gastric carcinoma were re-
garded as outcome events, and all other deaths
were considered censored events.  Differences
between survival distributions were tested for
statistical significance by log rank analysis.  All
statistical analyses were performed using the
StatView-5.0 software package for Macintosh
(Abacus Concepts Inc., Berkeley, CA).  P values
less than 0.05 were considered to be statistically
significant.
Results
The incidence of developing gastric car-
cinoma in the remnant stomach
In the 2,880 patients who underwent distal par-
tial gastrectomy between 1960 and 1985, 36 pa-
tients (RGC-BD: 8 patients and RGC-GC: 28
patients) developed gastric carcinoma in their
remnant stomach by the end of 1999.  The inter-
vals between initial partial gastrectomy and de-
tection of RGC for these 36 patients are shown
in Table 1.  The mean interval between initial
operation and the detection of RGC of the 8 pa-
tients with RGC-BD was 178 months (125–228
months) and that of the 28 patients with RGC-
GC was 142 months (22–271 months).  Of the
2,880 patients, 1,951 patients (1,187 patients
for benign diseases and 764 patients for gastric
carcinomas) survived more than 10 years after
partial gastrectomy.  Newly developed gastric
carcinomas in the remnant stomach more than
10 years after initial operation were detected in
8 of 1,187 (0.7%) patients for benign diseases
and in 19 of 764 (2.5%) patients for gastric car-
cinomas.  Among the 516 colorectal carcinoma
patients (control patients), 226 patients were
followed up more than 10 years after surgery
and 7 patients (3.1%) were found to have gas-
tric carcinoma.  The details of the incidence of
developing RGCs after partial gastrectomy are
shown in Table 2.  In our case-control study,
estimated risks (odds ratios) of the development
of RGCs after partial gastrectomy for benign
diseases and for gastric carcinomas were low
(0.212 and 0.798, Table 2).
Table 1.  The interval (in years) between
primary operation and detection of RGC in
36 patients
        Year after              Number of patients with
   gastric resection           RGC-BD      RGC-GC
< 4 0 5
  5 – 9 0 4
10 – 14 4 11
15 – 19 4 5
20 ≤ 0 3
            Total 8 28
RGC, remnant gastric carcinoma; RGC-BD, RGC
detected after distal partial gastrectomy for benign
gastroduodenal disease; RGC-GC, RGC detected
after distal partial gastrectomy for gastric carcinoma.
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Clinicopathological differences between
RGCs and PGC in the upper third of the
stomach
Clinicopathological findings of 18 patients with
RGC-BD, 16 patients with RGC-GC and 299
patients with PGC are shown in Table 3.  No sta-
tistically significant differences were observed
among the 3 groups (as assessed in terms of
patient age, histologic type, tumor size and dis-
tribution of histologic stage).  Remnant gastrec-
tomy was performed for 28 patients (RGC-BD:
15 and RGC-GC: 13).  Because of distant
metastases or the degree of  advancement of
gastric carcinomas, gastrectomy could not be
performed in 6 patients with RGC (RGC-BD: 3
and RGC-GC: 3).  The resectability rate of
RGC-BD was 83% and that of RGC-GC was
81%.  Partial remnant gastrectomy was performed
for 2 patients and total remnant gastrectomy
was done for the remaining 26 patients with
RGC.  In the 299 patients with PGC, total gas-
trectomy was performed for 173, and proximal
gastrectomy for the remaining 126 patients.
One patient with RGC-BD and 18 patients with
PGC died from postoperative complications
(total gastrectomy: 12 and proximal gastrecto-
my: 6).  The postoperative mortality rates of the
3 groups were not significantly different (Table
3).  Among patients who underwent resection of
the stomach, 8 patients with RGC-BD, 4 pa-
tients with RGC-GC and 107 patients with PGC
had died from gastric carcinoma by the end of
1999.  The 5-year survival rate for the 299
patients with PGC was 55%, while that for the
15 patients with RGC-BD was 43%, and that for
the 13 patients with RGC-GC was 65%, as
estimated by the Kaplan-Meier method.  No
statistically significant difference was found
among the 3 survival curves by the log rank test
(P = 0.548, Fig. 1).
Pathological differences between RGC-
BD and RGC-GC
The initial operative procedure and histologic
type of tumor of patients with RGC-BD were
not different from those of patients with RGC-
GC.  However, the interval between the initial
operation and detection of RGCs was longer in
RGC-BD than in RGC-GC (P = 0.004).  Ac-
cording to our classification of the location of
RGCs (Ikeguchi et al., 1994), RGCs were more
Table 2.  The incidence of developing gastric carcinoma in the remnant stomach more than
10 years after partial gastrectomy
      Initial operation for Total number Number of patients† Odds ratio
of patients (%) [95% confidence limit]
Benign gastroduodenal disease
Total 1187   8 (0.8)* 0.212 [0.083–0.539]
Operative procedure
      Billroth I 902   7 (0.8)****
      Billroth II 285   1 (0.4)*****
Gastric carcinoma
Total 764 19 (2.5)** 0.798 [0.332–1.919]
Operative procedure
      Billroth I 469 12 (2.6)******
      Billroth II 295   7 (2.4)*******
Control group 226   7 (3.1)*** 1.00
† Patients with newly developed gastric carcinoma in the remnant stomach.
Control group:  patients with colorectal carcinoma who were followed up for more than 10 years after
colorectal operation.
Statistically significant differences were observed between * and ** (P = 0.001) and between * and *** (P
= 0.001).
No significant differences were detected between ** and *** (P = 0.614), between **** and ***** (P =
0.444) or between ****** and ******* (P = 0.873).
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frequently detected at the site of anastomosis in
patients with RGC-BD (50%) than in patients
with RGC-GC (19%, P = 0.057, Table 4).
Moreover, 10 of 12 tumors (83%) located at the
anastomotic site were the diffuse type while, in
contrast, only 7 of 22 tumors (32%) located at
other sites were the diffuse type.  The difference
was significant (P = 0.004).  However, no sig-
nificant correlations were detected between
initial operative procedures (B-I or B-II) and
the location of RGCs (P = 0.799) or between
initial operative procedures and the histologic
types of tumors (P = 0.492).  The interval be-
tween the initial operation and detection of
RGCs of 12 tumors located at the anastomotic
site (mean: 232 months) was longer than that of
22 tumors located at other sites (mean: 205
months, P = 0.027).  Based on these results,
Table 3.  Clinicopathological differences among RGC-BD, RGC-GC and PGC
RGC-BD RGC-GC PGC P
[18] [16]  [299]
Age (mean, year) 63.7 64.3   59.4 0.098
Gender
     Male/female 16/2   8/8 204/95 0.05
Histologic type
     Diffuse type/intestinal type   8/10   9/7 172/127 0.557
Tumor size (mean, cm)   6.2   6.1     7.1 0.374
Stage
     IA   3   6   59
     IB   2   2   26
     II   3   1   54 0.569
     IIIA   1   2   60
     IIIB   4   1   36
     IV   5   4   64
Operative mortality (%)   1/15 (6.7)   0/13 (0) 18/299 (7.9) 0.655
[  ], number of patients.
PGC, primary gastric carcinoma located in the upper third of the stomach; RGC, remnant gastric carcinoma;
RGC-BD, RGC after partial gastrectomy for benign disease; RGC-GC, RGC after partial gastrectomy for
gastric carcinoma.
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Fig. 1.  Survival curve for 299 patients with PGC ( — ), for 15 patients with RGC-BD ( — ) and for
13 patients with RGC-GC ( — ) are shown.  No statistically significant difference was found among the
3 survival curves by the log rank test (P = 0.548).
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RGC-BD seems to develop frequently at the
anastomotic site and its development seems to
take longer than that of RGC-GC.
Discussion
The partial distal gastrectomy for benign gas-
troduodenal diseases has been considered to be
a risk factor of developing RGC.  However,
whether gastric resection implies an increased
risk for carcinoma remains a matter of dispute.
Tersmette et al. (1991) calculated the estimated
risk of developing RGC after distal partial
gastrectomy for benign gastroduodenal diseases
from reports previously published.  According
to their data, the estimated risk ranged from 0.2
to 4.4, and they reported that the weighted mean
relative risk of RGC-BD in Japan was 0.28; sig-
nificantly lower than that of RGC-BD in
Europe (1.66).  In our case-control study, the
estimated risk (odds ratios) of developing RGC
after partial gastrectomy for benign diseases
was 0.212.  Tersmette et al. (1991) reported that
a very high incidence of primary gastric cancer
in Japan statistically resulted in a decreased risk
for RGC-BD.  On the other hand, primary gas-
tric cancer has been much less common in
Europe, thus the risk of RGC-BD relatively in-
creased.  Interestingly, Harrison et al. (1997)
reported that total caloric intake increased the
risk of developing gastric carcinoma and that
dietary fiber intake decreased this risk.  In Italy,
high intake of meat, salted fish, seasoned
cheese and traditional foods were reported as
risk factors in the development of gastric carci-
noma (Buiatti et al., 1991; La Vecchia et al.,
1995).  Geographical variance and dietary
differences between Japanese and European
people need to be correlated with the incidence
of RGC-BD.
To date, RGC-GC has not been thoroughly
discussed.  In investigating RGC-GC, the possi-
bility of overlooking multiple synchronous
small carcinomas in the remnant stomach or the
possibility of cancer recurrence in the remnant
stomach has been considered major difficulties.
Overlooking small carcinomas in the remnant
stomach at the time of initial partial gastrec-
tomy has also been a problem in investigating
RGC-BD.  Many reports from Western coun-
tries have required that the interval between the
initial operation and detection of RGC should
be more than 5 years to avoid these possibilities
(Luukkonen et al., 1990; Pointner et al., 1994).
Kosaka et al. (1990) reported that the rate of
occurrence of synchronous multiple gastric car-
cinomas was 5.8% by macroscopic examina-
tion, though the rate increased to 13.2% after
microscopic examination of the stomach.
Kodera et al. (1995) reported that in only 53%
of patients with synchronous multiple gastric
carcinomas, the lesions were detected before
operation.  Moreover, they concluded that
overlooking one or more microscopic neoplas-
tic lesions might result in the development of
cancer of the gastric remnant within 10 years
after initial partial gastrectomy for benign or
Table 4.  Clinicopathological differences between RGC-BD and RGC-GC
RGC-BD RGC-GC P
[18] [16]
Reconstruction of initial operation
     Billroth I/Billroth II 8/10 10/6 0.292
Histologic type
     Diffuse type/intestinal type 8/10 9/7 0.472
Interval between initial operation and detection of RGC
     (mean, month) 265 167 0.004
Location of tumor
     Anastomotic site/other site 9/9 3/13 0.057
[  ], number of patients.
RGC, remnant gastric carcinoma; RGC-BD, RGC after partial gastrectomy for benign disease; RGC-GC,
RGC after partial gastrectomy for gastric carcinoma.
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malignant conditions.  Thus, in the study, to
avoid the possibility of overlooking microscop-
ic gastric carcinoma and to avoid the possibility
of recurrence of carcinoma, we required 10
years or more for the interval between the initial
partial gastrectomy and the detection of carci-
noma in the remnant stomach.  In the present
study, the estimated risk of developing meta-
chronous gastric carcinoma in the remnant
stomach after partial gastrectomy for gastric
carcinoma was 0.798.
Some reports have estimated the risk of
developing RGC based on the mortality rate
(Luukkonen et al., 1990) or the incidence rate
(Domellöf and Janunger, 1977) for gastric car-
cinoma in their countries (cohort studies).  We
conducted a hospital-based case-control study.
As a control group, we selected patients with
colorectal carcinoma.  The possibility of selec-
tion bias in terms of the control group should be
considered in any hospital-based study compar-
ed with a population-based study.  Moreover,
our control patients were not matched with pa-
tients who underwent partial gastrectomy in
terms of age and sex.  However, hospital-based
individuals generally provide higher compli-
ance and accuracy of information.  We checked
the control patients, who were determined to
have no gastric carcinomas in their stomachs,
before colorectal operation and they were fol-
lowed up for a long time at our hospital.  The
clinical records of the control patients could be
obtained every year and the incidence of devel-
oping gastric carcinoma could be accurately
calculated.
What is the difference between RGC-BD
and RGC-GC?  Histologic distribution and
stage distribution were not significantly differ-
ent among the RGC-BD, RGC-GC and PGC
groups.  Moreover, the prognosis of patients op-
erated on for RGC-BD was not different from
that of patients operated on for RGC-GC or
from that of patients with PGC.  The same result
was obtained by Kodera et al. (1996).  Although
no significant difference was found, RGCs
located in the anastomotic area were frequently
detected in RGC-BD, while, in contrast, RGCs
located in other sites were frequently found in
RGC-GC.  The interval between the initial op-
eration and detection of RGC was longer in
RGC-BD than in RGC-GC.  Moreover, 83% of
tumors located at the anastomotic site were the
diffuse type, while only 32% of tumors located
at other sites were the diffuse type (P = 0.004).
The interval between the initial operation and
detection of RGCs of tumors located at the
anastomotic site was longer than that of tumors
located at other sites (P = 0.027).  These find-
ings indicate that the carcinogenesis of RGC-
GC is in some regard different from that of
RGC-BD.
In the previous study, we investigated the
proliferative activity of normal gastric mucosa
adjacent to carcinoma in 13 patients with RGC
by flow cytometry (Ikeguchi et al., 1995).  We
reported that the percentages of the S + G2M
phase of the normal mucosa in anastomotic
areas from 5 patients with RGC-BD was sig-
nificantly higher than those from 8 patients with
RGC-GC.  Assad and Eastwood (1980) report-
ed that epithelial proliferation, assessed in biop-
sies morphologically, was increased signifi-
cantly in the fundic mucosa of patients after
antrectomy, as compared to the fundic mucosa
of normal controls.  These findings indicate that
the increase in proliferation of cells in the mu-
cosa of the remnant stomach is closely related
to the extent of exposure of the gastric mucosa
to the duodenal contents.  Duodenogastric bile
reflux after distal partial gastrectomy was found
to induce carcinoma at the anastomotic site in
animal experiments (Nishidoi et al., 1984).
Dysplasia, intestinal metaplasia and atrophy of
the normal mucosa have frequently been ob-
served at the anastomotic area of the remnant
stomach (Offerhaus et al., 1989).  These changes
in the gastric mucosa, considered to be the
result of duodenogastric reflux into the remnant
stomach, have been suggested to be the initial
signs of developing RGC-BD.  In contrast, de-
veloping RGC-GC has the characteristics of
multifocal cancer; it develops relatively quickly
and most lesions are located at sites remote
from the anastomosis.
To realize the carcinogenesis of RGC, fur-
ther investigations about the normal epithelium
of the gastric remnant are necessary.
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